These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 7610502)
1. Establishment of a new human urinary bladder mixed carcinoma cell line UMK-1 and its cell-density-dependent secretion of gelatinases and tissue inhibitor of metalloproteinase-1. Muraoka K; Nabeshima K; Kataoka H; Kishi J; Koono M Urol Int; 1995; 54(4):184-90. PubMed ID: 7610502 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder. Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862 [TBL] [Abstract][Full Text] [Related]
3. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. Hara I; Miyake H; Hara S; Arakawa S; Kamidono S J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973 [TBL] [Abstract][Full Text] [Related]
4. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells]. Kikkawa F Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829 [TBL] [Abstract][Full Text] [Related]
5. 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells. González-Avila G; Iturria C; Vadillo F; Terán L; Selman M; Pérez-Tamayo R Pathobiology; 1998; 66(1):5-16. PubMed ID: 9577961 [TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Brown JL; Russell PJ; Philips J; Wotherspoon J; Raghavan D Br J Cancer; 1990 Mar; 61(3):369-76. PubMed ID: 2328200 [TBL] [Abstract][Full Text] [Related]
7. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Kawamata H; Kawai K; Kameyama S; Johnson MD; Stetler-Stevenson WG; Oyasu R Int J Cancer; 1995 Nov; 63(5):680-7. PubMed ID: 7591285 [TBL] [Abstract][Full Text] [Related]
8. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752 [TBL] [Abstract][Full Text] [Related]
9. [Primary culture of human bladder carcinomas and establishment of human bladder carcinoma cell line by serum-free culture]. Ito H; Yamaguchi K; Kotake T; Matsuzaki O Nihon Hinyokika Gakkai Zasshi; 1989 Dec; 80(12):1749-54. PubMed ID: 2625822 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation. Padgett LC; Lui GM; Werb Z; LaVail MM Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473 [TBL] [Abstract][Full Text] [Related]
11. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Reid LM; Leav I; Kwan PW; Russell P; Merk FB Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211 [TBL] [Abstract][Full Text] [Related]
13. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267 [TBL] [Abstract][Full Text] [Related]
14. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of a tissue inhibitor of metalloproteinases-1 (TIMP-1) in bladder cancer patients. Naruo S; Kanayama H; Takigawa H; Kagawa S; Yamashita K; Hayakawa T Int J Urol; 1994 Sep; 1(3):228-31. PubMed ID: 7614380 [TBL] [Abstract][Full Text] [Related]
16. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Lokeshwar BL; Selzer MG; Block NL; Gunja-Smith Z Cancer Res; 1993 Oct; 53(19):4493-8. PubMed ID: 7691397 [TBL] [Abstract][Full Text] [Related]
17. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. Ozdemir E; Kakehi Y; Okuno H; Yoshida O J Urol; 1999 Apr; 161(4):1359-63. PubMed ID: 10081908 [TBL] [Abstract][Full Text] [Related]
18. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder. Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444 [TBL] [Abstract][Full Text] [Related]
19. Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium. Jones BE; Moshyedi P; Gallo S; Tombran-Tink J; Arand G; Reid DA; Thompson EW; Chader GJ; Waldbillig RJ Exp Eye Res; 1994 Sep; 59(3):257-69. PubMed ID: 7821370 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation. Russell PJ; Jelbart M; Wills E; Singh S; Wass J; Wotherspoon J; Raghavan D Int J Cancer; 1988 Jan; 41(1):74-82. PubMed ID: 3335421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]